These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 23972588)

  • 21. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia.
    de la Serna E; Andrés-Perpiñá S; Puig O; Baeza I; Bombin I; Bartrés-Faz D; Arango C; Gonzalez-Pinto A; Parellada M; Mayoral M; Graell M; Otero S; Guardia J; Castro-Fornieles J
    Schizophr Res; 2013 Jan; 143(1):125-31. PubMed ID: 23182439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and cognitive correlates of insight in first-episode schizophrenia.
    Chan SK; Chan KK; Lam MM; Chiu CP; Hui CL; Wong GH; Chang WC; Chen EY
    Schizophr Res; 2012 Mar; 135(1-3):40-5. PubMed ID: 22245186
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
    Reichenberg A; Weiser M; Rabinowitz J; Caspi A; Schmeidler J; Mark M; Kaplan Z; Davidson M
    Am J Psychiatry; 2002 Dec; 159(12):2027-35. PubMed ID: 12450952
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cognitive insight in schizophrenia: the missing link between insight and neurocognitive complaint?
    Tastet H; Verdoux H; Bergua V; Destaillats JM; Prouteau A
    J Nerv Ment Dis; 2012 Oct; 200(10):908-10. PubMed ID: 23034576
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insight in stable schizophrenia: relations with psychopathology and cognition.
    Mingrone C; Rocca P; Castagna F; Montemagni C; Sigaudo M; Scalese M; Rocca G; Bogetto F
    Compr Psychiatry; 2013 Jul; 54(5):484-92. PubMed ID: 23332554
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and neuropsychological correlates of insight in schizophrenia and bipolar I disorder: does diagnosis matter?
    Varga M; Magnusson A; Flekkøy K; David AS; Opjordsmoen S
    Compr Psychiatry; 2007; 48(6):583-91. PubMed ID: 17954145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Brief cognitive assessment instruments in schizophrenia and bipolar patients, and healthy control subjects: a comparison study between the Brief Cognitive Assessment Tool for Schizophrenia (B-CATS) and the Screen for Cognitive Impairment in Psychiatry (SCIP).
    Cuesta MJ; Pino O; Guilera G; Rojo JE; Gómez-Benito J; Purdon SE; Franco M; Martínez-Arán A; Segarra N; Tabarés-Seisdedos R; Vieta E; Bernardo M; Crespo-Facorro B; Mesa F; Rejas J
    Schizophr Res; 2011 Aug; 130(1-3):137-42. PubMed ID: 21652178
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of illness severity, cognition, and estimated antipsychotic dopamine receptor occupancy on insight into the illness in schizophrenia: An analysis of clinical antipsychotic trials of intervention effectiveness (CATIE) data.
    Ozzoude M; Nakajima S; Plitman E; Chung JK; Kim J; Iwata Y; Caravaggio F; Takeuchi H; Uchida H; Graff-Guerrero A; Gerretsen P
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Mar; 89():207-213. PubMed ID: 30172739
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thought disorder severity in compromised, deteriorated, and preserved intellectual course of schizophrenia.
    Mercado CL; Johannesen JK; Bell MD
    J Nerv Ment Dis; 2011 Feb; 199(2):111-6. PubMed ID: 21278540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Executive deficits: a continuum schizophrenia-bipolar disorder or specific to schizophrenia?
    Ancín I; Cabranes JA; Santos JL; Sánchez-Morla E; Barabash A
    J Psychiatr Res; 2013 Nov; 47(11):1564-71. PubMed ID: 23907000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cognitive impairment in schizophrenia: a life span perspective.
    O'Donnell BF
    Am J Alzheimers Dis Other Demen; 2007; 22(5):398-405. PubMed ID: 17959875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Schizophrenia with obsessive-compulsive disorder and obsessive-compulsive disorder with poor insight: a neuropsychological comparison.
    Tumkaya S; Karadag F; Oguzhanoglu NK; Tekkanat C; Varma G; Ozdel O; Ateşçi F
    Psychiatry Res; 2009 Jan; 165(1-2):38-46. PubMed ID: 18995914
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Differentiation of deficit and non-deficit schizophrenia based on cognitive functions].
    Polgár P
    Ideggyogy Sz; 2011 Mar; 64(3-4):128-32. PubMed ID: 21545010
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unaffected control of distractor interference in schizophrenia: a meta-analysis of incompatibility slowing in flanker tasks.
    Westerhausen R; Kompus K; Hugdahl K
    J Psychiatr Res; 2013 Feb; 47(2):246-51. PubMed ID: 23140904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association between self-disorders and neurocognitive dysfunction in schizophrenia.
    Haug E; Øie M; Melle I; Andreassen OA; Raballo A; Bratlien U; Lien L; Møller P
    Schizophr Res; 2012 Mar; 135(1-3):79-83. PubMed ID: 22137461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insight in bipolar disorder: associations with cognitive and emotional processing and illness characteristics.
    van der Werf-Eldering MJ; van der Meer L; Burger H; Holthausen EA; Nolen WA; Aleman A
    Bipolar Disord; 2011 Jun; 13(4):343-54. PubMed ID: 21843274
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive functioning during full and partial remission (positive and negative symptomatic remission) of schizophrenia.
    Braw Y; Benozio A; Levkovitz Y
    Schizophr Res; 2012 Dec; 142(1-3):122-8. PubMed ID: 23127380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Social skills and behavioral problems in schizophrenia: the role of mental state attribution, neurocognition and clinical symptomatology.
    Brüne M; Schaub D; Juckel G; Langdon R
    Psychiatry Res; 2011 Nov; 190(1):9-17. PubMed ID: 20417974
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Associations of symptoms, neurocognition, and metacognition with insight in schizophrenia spectrum disorders.
    Chan KK
    Compr Psychiatry; 2016 Feb; 65():63-9. PubMed ID: 26773992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling.
    Kanchanatawan B; Maes M
    CNS Neurol Disord Drug Targets; 2018; 17(6):473-486. PubMed ID: 29968545
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.